Rights and permissions
About this article
Cite this article
Adalimumab provides sustained QOL improvement in RA. Pharmacoecon. Outcomes News 457, 10 (2004). https://doi.org/10.2165/00151234-200404570-00018
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404570-00018